GOSH appoints new Chief Operating Officer

13 Aug 2020, 9:09 a.m.

John Quinn, Chief Operating Officer at GOSH

John Quinn has been appointed as Great Ormond Street Hospital’s (GOSH) new Chief Operating Officer.

Following a thorough recruitment process, John will be joining the Trust at the end of the calendar year from Moorfields Eye Hospitals NHS Foundation Trust where he is the Chief Operating Officer.

A pharmacist by background, John has also worked at University College London Hospitals NHS Foundation Trust and Buckinghamshire Healthcare NHS Trust and has a wealth of senior and Board-level leadership and management experience.

John Quinn said:

“I have been impressed by the work done at Great Ormond Street Hospital for years. It’s an excellent organisation with a great staff team leading cutting-edge treatment for its patients.

“Coming from Moorfields I’m pleased to be able to bring my experience from one world-class Trust to another as GOSH continues on its journey to improvement to provide the best possible care and experience for patients, their families and staff. I’m really excited to be joining the team and playing my part in this.”

Great Ormond Street Hospital Chief Executive, Matthew Shaw said:

“I am delighted John will be joining our team. He has a broad range of experience across the NHS, including operational leadership in hospitals with a strong research agenda and those running successful commercial services.

“A pharmacist by background, he will also prove invaluable as we transform our medicine management with the building of a Children’s Medicines Centre as part of the next stage of our redevelopment.”

“John also understands the importance of the regional landscape and working with partners across North Central London and beyond to provide better more joined-up care for patients.”

John will join the hospital at the end of the calendar year. Phil Walmsley, who is Interim Chief Operating Officer, will remain in post until then.

Four research projects receive funding to improve understanding and treatment of childhood cancer

Researchers at Great Ormond Street Hospital (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have received funding from The Little Princess Trust for four childhood cancer research projects.

New study brings hope for children with rare life-threatening kidney disease

New research funded by Great Ormond Street Hospital Charity (GOSH Charity), LifeArc and Kidney Research UK has taken an important step towards developing a new treatment for serious genetic kidney diseases affecting children.

Building the next generation of paediatric research leaders

From early career clinicians to emerging scientists, the NIHR GOSH Biomedical Research Centre (BRC)’s Academic Training Weekend is shaping the future of paediatric research - bringing together talent, expertise and ambition from across the UK.

Bagri family philanthropy enables UCL study into rare childhood neurological condition treated at GOSH

A generous donation from the Bagri family will underpin a landmark study into gene-editing treatments for Dihydropteridine reductase deficiency (DHPR deficiency), an ultra-rare childhood neurological condition, treated at GOSH